Stephanie Pons, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrolides | 2 | 2021 | 205 | 1.290 |
Why?
|
| Meningitis, Bacterial | 1 | 2023 | 225 | 0.710 |
Why?
|
| HLA-DR Antigens | 1 | 2021 | 607 | 0.680 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 4427 | 0.590 |
Why?
|
| Propofol | 1 | 2022 | 608 | 0.540 |
Why?
|
| Capillary Permeability | 1 | 2020 | 773 | 0.540 |
Why?
|
| Escherichia coli | 3 | 2023 | 4211 | 0.420 |
Why?
|
| Endothelial Cells | 4 | 2022 | 3587 | 0.390 |
Why?
|
| Sepsis | 3 | 2020 | 2601 | 0.370 |
Why?
|
| Receptors, Nicotinic | 3 | 2018 | 494 | 0.350 |
Why?
|
| Critical Illness | 2 | 2020 | 2755 | 0.280 |
Why?
|
| Intensive Care Units | 4 | 2022 | 3801 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 7463 | 0.240 |
Why?
|
| Antibodies, Bacterial | 3 | 2023 | 1478 | 0.240 |
Why?
|
| Bacteria | 3 | 2023 | 2221 | 0.240 |
Why?
|
| Nicotine | 2 | 2018 | 680 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2022 | 38 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2016 | 590 | 0.180 |
Why?
|
| Nicotinic Agonists | 2 | 2024 | 266 | 0.180 |
Why?
|
| Myelopoiesis | 1 | 2021 | 135 | 0.180 |
Why?
|
| Hypnosis | 1 | 2019 | 84 | 0.150 |
Why?
|
| Analgesia | 1 | 2023 | 460 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2020 | 325 | 0.150 |
Why?
|
| Conscious Sedation | 1 | 2022 | 534 | 0.150 |
Why?
|
| Nicotinic Antagonists | 1 | 2018 | 94 | 0.150 |
Why?
|
| Immunomodulation | 1 | 2021 | 549 | 0.140 |
Why?
|
| Biofilms | 3 | 2020 | 634 | 0.140 |
Why?
|
| Mitochondria, Liver | 1 | 2018 | 190 | 0.140 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 387 | 0.140 |
Why?
|
| Self Administration | 1 | 2018 | 388 | 0.140 |
Why?
|
| Alcohols | 1 | 2017 | 94 | 0.140 |
Why?
|
| beta-Glucans | 1 | 2016 | 129 | 0.120 |
Why?
|
| Streptococcus | 1 | 2015 | 198 | 0.120 |
Why?
|
| Histones | 2 | 2022 | 2592 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 731 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 1188 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1855 | 0.120 |
Why?
|
| Enterobacteriaceae | 1 | 2016 | 161 | 0.120 |
Why?
|
| Zoonoses | 1 | 2015 | 180 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2022 | 2721 | 0.110 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 189 | 0.110 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2016 | 190 | 0.110 |
Why?
|
| beta-Lactamases | 1 | 2016 | 307 | 0.110 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 400 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2018 | 708 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 2006 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 1889 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2023 | 3666 | 0.100 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 354 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2016 | 1063 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 9562 | 0.100 |
Why?
|
| Pandemics | 2 | 2022 | 8753 | 0.090 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 436 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2018 | 1609 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 796 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 2635 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 619 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2023 | 2400 | 0.090 |
Why?
|
| Critical Care | 1 | 2022 | 2716 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1943 | 0.080 |
Why?
|
| Humans | 21 | 2024 | 768393 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 3112 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2016 | 1397 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3078 | 0.070 |
Why?
|
| Thrombosis | 1 | 2021 | 2955 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2023 | 4738 | 0.070 |
Why?
|
| Mice | 7 | 2024 | 82017 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3486 | 0.070 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 3838 | 0.060 |
Why?
|
| Neurons | 1 | 2024 | 9513 | 0.060 |
Why?
|
| Superior Cervical Ganglion | 1 | 2024 | 33 | 0.060 |
Why?
|
| Animals | 10 | 2024 | 169337 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4414 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4677 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2024 | 233 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 518 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2023 | 172 | 0.050 |
Why?
|
| Phenylurea Compounds | 1 | 2024 | 530 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 13503 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2015 | 6606 | 0.040 |
Why?
|
| France | 1 | 2021 | 497 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 292 | 0.040 |
Why?
|
| Endothelium | 1 | 2022 | 768 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 425 | 0.040 |
Why?
|
| Transducers | 1 | 2020 | 245 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2021 | 595 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 16028 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2018 | 70 | 0.040 |
Why?
|
| Morphine | 1 | 2023 | 658 | 0.040 |
Why?
|
| Benzamides | 1 | 2024 | 1380 | 0.040 |
Why?
|
| Calcium | 2 | 2024 | 5794 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2022 | 1342 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2018 | 380 | 0.040 |
Why?
|
| Cytochromes c | 1 | 2018 | 173 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 179 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2021 | 680 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 423 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2015 | 102 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 2015 | 144 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 1020 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 1623 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2015 | 364 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 138 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2018 | 2176 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2015 | 277 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2015 | 148 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2020 | 774 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3439 | 0.030 |
Why?
|
| Schools | 1 | 2021 | 1496 | 0.030 |
Why?
|
| Blood | 1 | 2015 | 597 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 1298 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2016 | 762 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2015 | 582 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 1765 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2016 | 502 | 0.020 |
Why?
|
| Male | 6 | 2020 | 364902 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2021 | 3230 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 5496 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 22385 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 3520 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81801 | 0.020 |
Why?
|
| Reward | 1 | 2017 | 984 | 0.020 |
Why?
|
| Female | 5 | 2020 | 397089 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1838 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2015 | 1530 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2015 | 1057 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 2884 | 0.020 |
Why?
|
| Attention | 1 | 2019 | 2425 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3779 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1905 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 985 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 5831 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2201 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 2843 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12422 | 0.020 |
Why?
|
| Self Report | 1 | 2019 | 3766 | 0.020 |
Why?
|
| Heart Rate | 1 | 2019 | 4218 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54920 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7064 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3836 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5367 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8506 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12870 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5404 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3922 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11668 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7880 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4775 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 10089 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 23835 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 171562 | 0.010 |
Why?
|
| Genotype | 1 | 2015 | 13042 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22355 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40272 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 223491 | 0.010 |
Why?
|
| Child | 1 | 2021 | 80891 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74962 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 223640 | 0.000 |
Why?
|